Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
Open | $5.240 |
Close | - |
Volume / Avg. | 10.731K / 338.830K |
Day Range | 5.220 - 5.340 |
52 Wk Range | 1.930 - 6.790 |
Market Cap | $318.132M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 0.55% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and SNDL (NASDAQ:SNDL).
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by B of A Securities on Monday, March 25, 2024. The analyst firm set a price target for 11.00 expecting LYRA to rise to within 12 months (a possible 106.57% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $5.325 last updated Today at April 23, 2024 at 10:39 AM EDT.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.